Lentitek

Edinburgh, GB · 1 known investors

Lentitek develops manufacturing technology to improve the production quality, yield, and efficacy of lentiviral vectors used in advanced therapies such as CAR-T and gene therapies. The company's proprietary method is designed to enable new therapeutic applications and integrate into existing manufacturing processes.